Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-27 @ 11:31 PM
Study NCT ID:
NCT06942234
Status:
RECRUITING
Last Update Posted:
2025-09-17
First Post:
2025-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer
Sponsor:
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JSKN016-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None